Document:

_

EXHIBIT 10.1

LOAN AGREEMENT

THIS LOAN AGREEMENT (this “Agreement”), is executed as of June 9, 2008, by and between Voyant International Corporation a Nevada corporation (the “Company”), and The Blue Heron Family Trust, an Alaskan trust (the “Lender”).

WHEREAS, the Company is preparing to conduct a Private Investment in Public Equity offering (the “PIPE Offering”);

WHEREAS, in order to fund the Company’s operations until such PIPE Offering is completed, the Company wishes to borrow $702,703 from the Lender as a short-term bridge loan; 

WHEREAS, the Lender is willing to provide such financing on terms and conditions as set forth herein; and 

WHEREAS, the Loan (as defined below) will be secured by all the assets of the Company pursuant to the terms of a Security Agreement, dated as of February 29, 2008 (the “Security Agreement”).

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Lender, intending to be legally bound, agree as follows:

ARTICLE 1

DEFINITIONS

1.1

Defined terms. Certain capitalized terms used in this Agreement shall have the specific meanings defined below:

“Average Trading Price” shall mean the average closing bid price of the Company’s common stock for a period of 20 consecutive trading days prior to the Loan Closing Date.

“Business Day” shall mean a day other than a Saturday, Sunday, or other day on which commercial banks are authorized or required by law to close.

“Common Stock” shall mean the common stock of the Company.

“Default Rate” shall mean the higher of (a) the highest prime rate of interest per annum published in the Money Rate Table of the Western Edition of The Wall Street Journal, as adjusted on a daily basis, plus twelve and one-quarter percent (12.25%) per annum, or (b) twenty five (25.00%) per annum, in either case compounded annually. The occurrence of any Event of Default will result in the retroactive application of the Default Rate.

“Equity Securities” shall mean the capital stock of such person or entity and/or any Stock Equivalents of such person or entity.

“Indebtedness” shall mean:  (a) liabilities for borrowed money, (b) liabilities for the deferred purchase price of property (including all liabilities created or arising under any conditional sale or other title retention agreement with respect to any such property), (c) all liabilities appearing on the Company’s balance sheet in accordance with generally accepted accounting, (d) all liabilities for borrowed money secured by any lien with respect to any property owned by the Company (whether or not it has assumed or otherwise become liable for such liabilities), (e) all the Company’s liabilities in respect of letters of credit or instruments serving a similar function issued or accepted for its account by banks and other financial institutions (whether or not representing obligations for borrowed money); and (f) any guaranty of by the Company with respect to liabilities of a type described in any of clauses (a) through (e) hereof.

“Interest Rate” shall mean 15.00% compounded annually.

“Loan Closing Date” or “Closing Date” shall mean the date upon which the Loan is made to the Company.

“Stock Equivalents” of any person or entity shall mean options, warrants, calls, rights, commitments, convertible securities and other securities pursuant to which the holder, directly or indirectly, has the right to acquire (with or without additional consideration) capital stock or equity of such person or entity.

“Term” shall mean the period commencing with the Closing Date and expiring on the Maturity Date, unless terminated earlier pursuant to the terms of this Agreement.

 “WAA Collateral” shall mean “Collateral” as defined in that certain Secured Promissory Note, made by the Company to WAA, LLC dated November 9, 2006.

ARTICLE 2

THE LOAN

2.1

Loan.  According to the terms and subject to the conditions of this Agreement, the Lender shall make a loan to the Company on the Loan Closing Date in the amount of $702,703 in two advances as set forth in Section 2.3 below (the “Loan”).  The Loan shall be evidenced by a single promissory note in the form attached hereto as Exhibit A (“Note”), duly executed on behalf of the Company and dated as of the Loan Closing Date.

2.2

Interest.  The Loan shall bear interest (“Interest”) from the date of an advance by the Lender until the Maturity Date (as defined below) at the Interest Rate (calculated on the basis of the actual number of days elapsed over a year of 360 days).  Interest is payable by the Company on each 30—day anniversary of the date of this Agreement.  Notwithstanding anything to the contrary, in no event shall the Interest Rate be less than 15.00% per annum, nor shall the Interest Rate be adjusted to exceed the maximum amount permitted by applicable law.

2.3

Prepayment of the Loan.  The Company may from time to time prepay all or any portion of the Loan without premium or penalty of any type.  The Company shall give the Lender at least three (3) Business Day prior written notice of its intention to prepay the Loan, specifying the date of payment and the total amount of the Loan to be paid on such date.  Once any portion of the Loan has been repaid, the funds may not be re-borrowed.

2.4

Maturity Date.  Unless the Loan is earlier accelerated pursuant to the terms hereof, the Loan and all accrued Interest thereon shall be due and payable in full on the earlier of (i) the date that is three hundred and sixty (360) days following the Loan Closing Date; and (ii) the date on which the Company has received an aggregate of $3,500,000 from the sale(s) of its Equity Securities, from and after the Loan Closing Date, in one or a series of transactions (the “Maturity Date”).

2.5

Conversion Right. The Lender shall have the right, at Lender’s option, at any time after the completion of the Term, to convert all, or, in multiples of $1.00, any part of the Loan into shares of the Company’s Common Stock equal to the outstanding principal amount of the Loan divided by the Conversion Price.  

2.6

Conversion Price. The Loan will have a Conversion Price equal to the product of 0.8 multiplied by the Average Trading Price (the “Conversion Price”).

2.7

Forced Conversion. The Company shall have the right to force conversion of the Loan provided that the average closing bid price for the Common Stock for a period of 20 consecutive trading days exceeds a value equal to 5.0 multiplied by the Conversion Price.

2.8

Lender Approval of Subsequent Financing, Seniority.  The Company covenants and agrees that, until payment in full of all amounts due under this Agreement and the Note: 

(a)

The Company shall consult with Lender prior to seeking or applying for additional bridge funding, other loans (with the exception of lines of credit obtained for working capital, and trade payables incurred,  in the ordinary course of business), other Indebtedness, or equity or equity-linked financing, including, without limitation, the sale of any Equity Securities;  

(b)

The Company shall not accept, incur or enter into agreements for any additional bridge funding, other loans (with the exception of lines of credit obtained for working capital, and trade payables incurred, in the ordinary course of business), other Indebtedness (other than Indebtedness permitted under Section 2.8(d)), or equity or equity-linked financing, including, without limitation, the sale of any Equity Securities, without either (a) the prior written consent of Lender, which consent may be withheld in Lender’s sole discretion or (b) all amounts outstanding under the Loan being paid from the proceeds of such transaction; 

(c)

The Company shall not, and shall not permit any of its subsidiaries to, directly or indirectly declare or pay any dividend or make any distribution on account of the Common Stock of the Company or any Equity Securities of its subsidiaries (other than dividends or distributions payable to the Company) without the prior written consent of Lender, which consent may be withheld in Lender’s sole discretion; 

(d)

The Company shall not incur any Indebtedness (other than trade payables incurred in the ordinary course of business) without the prior written consent of Lender, which consent may be withheld in Lender’s sole discretion; and

(e)

The Company shall not voluntarily prepay any Indebtedness or any portion thereof (other than trade payables incurred in the ordinary course of business) without the prior written consent of Lender, which consent may be withheld in Lender’s sole discretion. 

ARTICLE 3

CONDITIONS PRECEDENT TO THE LOAN

3.1

Conditions on the Loan Closing Date.  The obligation of the Lender to make the Loan pursuant to Section 2.1 shall be subject to the satisfaction, on or before the Loan Closing Date, of the conditions set forth in this Section.  If the conditions set forth in this Section are not met on or prior to the Loan Closing Date, the Lender shall have no obligation to make the Loan. 

(a)

The Company shall have duly executed and delivered to the Lender the Note representing the Loan.

(b)

The Amended and Restated Security Agreement, dated as of February 29, 2008, to secure the repayment of all Obligations (as defined therein) to the Lender and granting the Lender a continuing security interest in all presently existing and hereafter acquired assets and property of the Company of whatever nature and wherever located, which such security interest shall be senior to all other security interests or encumbrances against the assets and property of the Company, except that security interest held by WAA, LLC in the WAA Collateral, shall be in full force and effect.

(c)

The Company shall have duly authorized, executed, and delivered to the Lender a Common Stock Purchase Warrant, in the form attached hereto as Exhibit B.

(e) 

There shall exist no material adverse change in the condition (financial or otherwise), results of operations, assets, properties or prospects of the Company since March 31, 2008, the date of the most recent financial statements provided to Lender. 

(f)

There shall exist no material default in any of the Company’s obligations under any contract or agreement.

(g)

The Company shall be in material compliance with all applicable laws. 

(h)

The Company shall have retained Gemini Partners, Inc. or GP Group, LLC as its exclusive financial advisor in connection with the PIPE Offering, and shall provide evidence of such engagement.

(i)

The Lender shall have received such other documents, certificates, or other materials as it reasonably requests from the Company with respect to the transaction contemplated by Agreement, the Note, and the Security Agreement.

(j)

The Amended and Restated Intercreditor Agreement between WAA, LLC and the Lender dated as of February 29, 2008 shall be in full force and effect. 

ARTICLE 4

REPRESENTATIONS AND WARRANTIES

4.1

Due Incorporation and Good Standing.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada with full and adequate power to carry on and conduct its business as presently conducted, and is duly licensed or qualified in all foreign jurisdictions wherein the failure to be so qualified or licensed would reasonably be expected to have a material adverse effect on the business of the Company.

4.2

Due Authorization.  The Company has full right, power and authority to enter into this Agreement, to make the borrowings hereunder and execute and deliver the Note as provided herein and to perform all of its duties and obligations under this Agreement, the Note, and the Security Agreement.  The execution and delivery of this Agreement, the Note, and the Security Agreement will not, nor will the observance or performance of any of the matters and things herein or therein set forth, violate or contravene any provision of law or the Company’s bylaws or certificate of incorporation.  All necessary and appropriate corporate action on the part of the Company has been taken to authorize the execution and delivery of this Agreement, the Note and the Security Agreement.  Concurrently with the execution of this Agreement, the Company will deliver to the Lender a copy of the minutes of the meeting of the Company’s Board of Directors authorizing the Company to enter into this Agreement, the Note and the Security Agreement, to make the borrowings as provided herein, and to perform all of its duties and obligations under this Agreement, the Note and the Security Agreement. 

4.3

Enforceability.  Each of this Agreement, the Note, and the Security Agreement has been validly executed and delivered by the Company and constitutes the legal, valid and binding obligations of the Company enforceable against it in accordance with its respective terms, subject to applicable bankruptcy, insolvency, reorganization or similar laws relating to or affecting the enforcement of creditors’ right and to the availability of the remedy of specific performance.

4.4

Capitalization.  All of the Company’s authorized and outstanding equity securities (including securities convertible into equity securities) are identified on Schedule A attached hereto.  Other than as set forth on Schedule A, there are no outstanding shares of capital stock or any options, warrants or other preemptive rights, rights of first refusal or similar rights to purchase equity securities of the Company.  Other than as set forth on Schedule B, the Company has no Indebtedness.  Schedule B sets forth a true and correct list of all Indebtedness of the Company including the maturity dates and payment obligations and schedules thereof.

4.5

Subsidiaries.  Except as disclosed on Schedule C, the Company owns no securities of any other entity, and there are no outstanding shares of capital stock or any options, warrants or other preemptive rights, rights of first refusal or similar rights to purchase equity securities of any other entity.  

4.6

Compliance with Laws.  The nature and transaction of the Company’s business and operations and the use of its properties and assets do not, and during the term of this Agreement shall not, violate or conflict with in any material respect any applicable law, statute, ordinance, rule, regulation or order of any kind or nature.

4.7

Absence of Conflicts.  The execution, delivery and performance by the Company of this Agreement, the Note, and the Security Agreement, and the transactions contemplated hereby and thereby, do not constitute a breach or default, or require consents under, any agreement, permit, contract or other instrument to which the Company is a party, or by which the Company is bound or to which any of the assets of the Company is subject, or any judgment, order, writ, decree, authorization, license, rule, regulation, or statute to which the Company is subject.

4.8

Litigation and Taxes.  Except as disclosed in Schedule D, there is no litigation or governmental proceeding pending, or to the best knowledge of the Company after due inquiry, threatened, against the Company. Except as disclosed in Schedule D, the Company has duly filed all applicable income or other tax returns and has paid all material income or other taxes when due.  Except as disclosed in Schedule D, there is no controversy or objection pending, or to the best knowledge of the Company after due inquiry, threatened in respect of any tax returns of the Company.

4.9

No Omissions or Misstatements.  None of the information included in this Agreement, other documents or information furnished or to be furnished by the Company contains any untrue statement of a material fact or is misleading in any material respect or omits to state any material fact.  Copies of all documents referred to herein have been delivered or made available to the Lender and constitute true and complete copies thereof and include all amendments, schedules, appendices, supplements or modifications thereto or waivers thereunder.

4.10

Financial Statements.  The financial statements of the Company are complete and correct, have been prepared from the books and records of the Company in accordance with generally accepted accounting principles consistently applied throughout the periods involved, except for changes specified therein and except that unaudited financial statements are not accompanied by notes, and present fairly the financial condition, results of operations, shareholders’ equity and changes in financial position of the Company and its consolidated Subsidiaries as of the dates thereof and for the periods specified therein.  Except as set forth in the balance sheet as of March 31, 2008 included in such financial statements or incurred in the ordinary course of business since March 31, 2008, the Company has no indebtedness, obligation or liability, absolute, accrued, contingent or otherwise, and there has been no material adverse change in the condition (financial or otherwise), results of operations, assets, properties or prospects of the Company.

4.11

Company Knowledge and Experience.  The Company (together with its accountants, legal counsel and other representatives with whom it has consulted in connection with this Agreement) has such knowledge, experience and access to professional advice in financial and business matters, including loans like the Loan, to be capable of evaluating the risks and merits of receiving the Loan pursuant to this Agreement, and the Company has 

obtained such professional third-party advice concerning the Loan and the transactions contemplated hereby as it has desired and deemed prudent.

4.12

Lender Security Interest.  The Lender holds a perfected security interest, or shall be able to effect such interest within a reasonable time after the Closing Date, in the Collateral (as defined in the Security Agreement).

ARTICLE 5

COVENANTS

5.1

Negative Covenants of the Company.  The Company covenants and agrees that, from the Loan Closing Date until the Maturity Date (and, in any event, during such time as any portion of the Loan or any Interest thereon is outstanding), without the prior written consent of the Lender, which consent may be withheld in Lender’s sole discretion, the Company will not:

(a)

create, incur, assume or suffer to exist, without the Lender’s prior written consent, which consent the Lender may withhold in its sole and absolute discretion, any secured Indebtedness (other than the Indebtedness related to the WAA Collateral) or any other Indebtedness (other than trade payables arising in the Company’s ordinary course of business) that is in any way senior or superior to this Agreement or the indebtedness represented hereby, except as permitted by Section 2.8(b);

(b)

issue any Equity Securities, except as permitted by Section 2.8(b) or pursuant to Stock Equivalents outstanding on the Loan Closing Date;

(c)

merge or consolidate with or into any other corporation or sell or otherwise convey 25% or more of its assets;

(d)

in a single transaction or series of related transactions, effect a significant acquisition of any business or entity (for purposes hereof, a “significant” acquisition shall be determined in accordance with Instructions 2, 3 and 4 or Item 2 of Form 8-K of the Securities and Exchange Commission);

(e)

engage in any business other than the business conducted by the Company on the Loan Closing Date;

(f)

declare, set aside or pay any dividend or other distribution on any of its capital stock;

(g)

engage in any transaction with any Affiliate (as such term is defined in Rule 501(b) of the Securities Act of 1933, as amended) on terms less favorable to the Company than could be obtained from an unrelated party;

(h)

amend its Articles of Incorporation or Bylaws in any manner that adversely affects the rights associated with this Agreement, the Common Stock issuable upon the exercise of the Warrant, or the Warrant; or

(i)

increase the principal amount of the Note above $702,703;

(j)

voluntarily prepay in whole or in part, or modify, any indebtedness outstanding on the Loan Closing Date, prior to the repayment of the Note in full, except that the Company may pay WAA, LLC $50,000 of the Company’s Indebtedness to WAA, LLC.

The Company will give notice to the Lender of any breach under any provisions of this Agreement within three (3) business days after the discovery by the Company of such breach.  

5.2

Affirmative Covenants of the Company.  The Company covenants and agrees that, from the Loan Closing Date until the Maturity Date (and, in any event, during such time as any portion of the Loan or any Interest thereon is outstanding), the Company shall:

(a)

operate its business only in the ordinary course, maintain its properties and assets in good repair, working order and condition, and conduct all transactions with third parties, including affiliates of the Company, on an arm’s length basis;

(b)

cause to be done all things reasonably necessary to maintain, preserve and renew its corporate existence and all material licenses, authorizations and permits necessary to the conduct of its businesses;

(c)

comply with all applicable laws, rules and regulations of all governmental authorities, the violation of which could reasonably be expected to have a material adverse effect on its business, properties or prospects;

(d)

deliver to the Lender within 15 days after the end of each fiscal month and within 30 days of the end of each fiscal quarter, (i) unaudited consolidated financial statements (including balance sheets, statements of income and loss, statements of cash flow and statements of shareholders’ equity) all in reasonable detail, fairly presenting the financial position and the results of operations of the Company as of the end of and through such periods, prepared in accordance with generally accepted accounting principles, consistently applied in the United States and consistent with past practice; (ii) a statement of any litigation or legal action pending or threatened against the Company certified as true and correct by the Company’s Chief Executive Officer; and (iii) such other reports as the Lender may reasonably request.  Lender acknowledges that said information will constitute material, nonpublic information and shall keep said information confidential until it has been publicly released by Company.

(e)

deliver to the Lender within five days after they are available (but in any event within ninety days after the end of each of its fiscal years) the Company’s audited annual financial statements and the Company’s annual budget, and allow the Lender reasonable access during normal business hours to visit the Company and inspect the financial records of the Company; and

(f)

provide the Lender with copies of all minutes of any meeting of the Board of Directors of the Company promptly after they become available, but in no event more than 4 days after the date of any meeting. 

ARTICLE 6

DEFAULT

6.1

Events of Default.  The occurrence of any of the following events (each an “Event of Default”), not cured in the applicable cure period, if any, shall constitute an Event of Default of the Company:

(a)

a breach of any representation, warranty, covenant or other provision of this Agreement, the Note or the Security Agreement, which, if capable of being cured, is not cured within three days following the earlier of (i) notice thereof to the Company and (ii) the Company becoming aware of such breach;

(b)

the failure to make when due any payment described in this Agreement, the Note or the Security Agreement, whether on or after the Maturity Date, by acceleration or otherwise; 

(c)

the failure of the Company to issue the Warrant to the Lender, and to thereafter comply with the terms thereof; or

(d)

(i) the application for the appointment of a receiver or custodian for the Company or the property of the Company, which application is not dismissed within 60 days, (ii) the entry of an order for relief or the filing of a petition by or against the Company under the provisions of any bankruptcy or insolvency law, which petition, in the case of a filing against the Company, is not dismissed within 60 days (iii) any assignment for the benefit of creditors by or against the Company, or (iv) the Company becomes insolvent.

6.2

Effect of Default.  Upon the occurrence of any Event of Default that is not cured within any applicable cure period, the Lender may elect, by written notice delivered to the Company, to take any or all of the following actions:  (i) declare this Agreement terminated and the outstanding amounts under the Note to be forthwith due and payable, whereupon the entire unpaid Loan, together with accrued and unpaid Interest thereon, and all other cash obligations hereunder, shall become forthwith due and payable, without presentment, demand, protest or any other further notice of any kind, all of which are hereby expressly waived by the Company, anything contained herein or in the Note or the Security Agreement to the contrary notwithstanding, (ii) increase the aggregate interest due to the Lender to be equal to the amount of the Loan multiplied by the Default Interest Rate from the Loan Closing Date until the Maturity Date (calculated on the basis of the actual number of days elapsed over a year of 360 days), as well as on any days Lender remains unpaid in full, including both principal and interest, following the Maturity Date and (iii) exercise any and all other remedies provided hereunder or available at law or in equity upon the occurrence and continuation of an Event of Default.  In addition, during the occurrence of any Event of Default, the Company shall not pay make any payment on any other outstanding indebtedness of the Company (other than indebtedness of the Company to which the Lender has agreed in writing to subordinate this Agreement and the Note hereunder).

ARTICLE 7

WARRANT

7.1

Issuance of Warrant.  The Company will issue to the Lender at the closing of the Loan a Common Stock Purchase Warrant (the "Warrant") to purchase common stock of Company in the form attached hereto as Exhibit C, appropriately completed as follows:

(a)

The number of shares for which the Warrant shall be exercisable shall be equal to the product of the Loan Amount and 1.5 multiplied by a fraction, the numerator of which is $1.00 and the denominator of which shall be equal to the average closing bid price of the Company’s common stock for a period of 20 consecutive trading days prior to the Closing Date (the “Average Trading Price”).  However, in the event that all or any portion of the Loan, all or any portion of the accrued Interest thereon and all other sums due hereunder and under the Note, have not been received by Lender on or before the date that is three hundred and sixty (360) days following the Loan Closing Date, the number of shares for which the Warrant shall be exercisable shall increase by ten percent (10%) per each thirty (30) day period or part thereof until the Loan and all accrued Interest are paid in full. The additional warrants shall herein be defined as the “Default Warrants” and the exercise price of the additional shares for which the Warrant shall be exercisable pursuant to the foregoing sentence shall be $0.01 per share.

(b)

Fifty percent (50%) of the shares for which the Warrant shall be exercisable shall have an exercise price equal to the Average Trading Price. The remaining shares for which the Warrant shall be exercisable shall have an exercise price equal to the product of the Average Trading Price and 1.5.

(c)

The date of the Warrant shall be the Loan Closing Date.

7.2

Warrant Obligations.  The Company shall comply on a timely basis with each and every obligation under the Warrant.  

7.3

Registration Rights.  The Lender shall have the registration rights provided in Section 3 of the Warrant, “Registration Rights”. 

ARTICLE 8

MISCELLANEOUS

8.1

Successors and Assigns; Participations.  Subject to the exceptions specifically set forth in this Agreement, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective executors, administrators, heirs, successors and assigns of the parties.  This Agreement may be assigned solely by the Lender.  Furthermore, although this Agreement, the Note and the Security Agreement name the Lender as the holder thereof and/or the lender thereunder, the Lender is authorized to sell participation interests in the Loan to one or more other persons or entities.  The Company agrees that:  (a) each holder of a participation interest will be entitled to rely on the terms of this Agreement, the Note and the Security Agreement as if such holder had been named as an original party hereto and thereto; and (b) the Lender is authorized to provide all information furnished by the Company to the Lender to each holder of a participation interest.

8.2

Titles and Subtitles.  The titles and subtitles of the Sections of this Agreement are used for convenience only and shall not be considered in construing or interpreting this agreement.

8.3

Notices.  Any notice, request or other communication required or permitted hereunder shall be in writing and shall be delivered personally or by facsimile (receipt confirmed electronically) or shall be sent by a reputable express delivery service or by certified mail, postage prepaid with return receipt requested, addressed as follows:

	
	if to Company, to:

Dana Waldman, CEO

	Voyant International Corporation

	444 Castro Street, Suite 318

	Mountain View, CA 94041

	Fax: (650) 691-4458

	 

	with a copy to:

	Richardson & Patel LLP

	10900 Wilshire Boulevard, Suite 500

	Los Angeles, CA 90024

	Attn: Benjamin M. Alexander, Esq.

	Fax: (310) 208-1154

	 

	if to the Lender, to:

The Blue Heron Family Trust

	Brothers Wealth Management, LLC

	815-A Brazos Street #228

	Austin, TX 78701

	Attn: Daryl D. Brown, Discretionary and Investment Trustee

	 

	with a copy to:

	Thompson & Knight L.L.P.

	1700 Pacific Ave., Suite 3300

	Dallas TX 75201

	Attn:  William J. Schuerger, Esq.

Either party hereto may change the above specified recipient or mailing address by notice to the other party given in the manner herein prescribed.  All notices shall be deemed given on the day when actually delivered as provided above (if delivered personally or by facsimile, provided that any such facsimile is received during regular business hours at the recipient’s location) or on the day shown on the return receipt (if delivered by mail or delivery service).

8.4

Governing Law.  This Agreement shall be governed by and construed in accordance with the domestic laws of the State of California without giving effect to any choice of law or conflict of law provision or rule (whether of the State of California or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of California.

8.5

Waiver and Amendment.  Any term of this Agreement may be amended, waived or modified with the written consent of the Company and the Lender.

8.6

Remedies.  No delay or omission by the Lender in exercising any of its rights, remedies, powers or privileges hereunder or at law or in equity and no course of dealing between the Lender and the undersigned or any other person shall be deemed a waiver by the Lender of any such rights, remedies, powers or privileges, even if such delay or omission is continuous or repeated, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise thereof by the Lender or the exercise of any other right, remedy, power or privilege by the Lender.  The rights and remedies of the Lender described herein shall be cumulative and not restrictive of any other rights or remedies available under any other instrument, at law or in equity.  

8.7

Expenses.  The Company shall pay all customary costs and expenses incurred by the Lender in connection with the negotiation and preparation of the documents contemplated by this Agreement and the Loan closing (including the Lender’s reasonable attorneys’ fees).

8.8

Integration.

This Agreement, along with the Note and the Security Agreement, constitutes the complete and exclusive agreement between the Company and the Lender with respect to the subject-matter herein and replaces and supersedes any and all other prior written and oral agreements or statements by such parties hereto relating to such subject-matter.

8.9

Prevailing Party.

If either party hereto brings any legal suit, action or proceeding against another party arising out of, relating to, or concerning the interpretation or the enforcement of rights and duties hereunder or any transaction related hereto (collectively, an “Action”), the losing party shall pay to the prevailing party a reasonable sum for attorneys’ fees and shall reimburse all costs (whether or not such costs are otherwise recoverable under the provisions of the California Code of Civil Procedure or other statutory law of California or any other jurisdiction) incurred in connection with the prosecution or defense of such Action and/or enforcement of any judgment, order, ruling or award granted therein, all of which shall be deemed to have accrued on the commencement of such Action and shall be paid whether or not such Action is prosecuted to a judgment, order, ruling or award.  “Prevailing Party” within the meaning of this Section includes, without limitation, a party which agrees to dismiss an Action on the other party’s payment of some or all sums allegedly due or performance of some or all of the covenants allegedly breached, or which obtains substantially the relief sought by it.

IN WITNESS WHEREOF, the Company has caused this Loan Agreement to be signed in its name on the date first set forth above.

			
	        

	 
	  

	 
	 
	 

	 
	By:  

	/s/ Daryl D. Brown

	 
	 
	Daryl D. Brown

Discretionary and Investment Trustee

The Blue Heron Family Trust

			
	 
	 
	  

	 
	 
	 

	 
	By:  

	/s/ David R. Wells

	 
	 
	David R. Wells

Chief Financial Officer

Voyant International Corporation

SCHEDULE A

CAPITALIZATION OF THE COMPANY

							
	 
	 
	Issued and

Outstanding

	 
	Options/

Warrants

	 
	Fully Diluted

	 
	 
	 
	 

	Common Shares

	 
	 
	 
	 
	 
	 

	Dana Waldman/WAA

	     

	—

	     

	17,000,000

	     

	17,000,000

	Mark Laisure

	 
	10,500,000

	 
	2,000,000

	 
	12,500,000

	Scott Fairbairn

	 
	15,000,000

	 
	2,000,000

	 
	17,000,000

	Herschel Stiles

	 
	—

	 
	3,000,000

	 
	3,000,000

	Steffen Koehler

	 
	—

	 
	3,000,000

	 
	3,000,000

	David Wells

	 
	100,000

	 
	2,800,000

	 
	2,900,000

	RHC Transaction

	 
	18,165,000

	 
	—

	 
	18,165,000

	Converted Noteholders

	 
	17,096,092

	 
	4,453,054

	 
	21,549,146

	Other Common Holders

	 
	57,612,900

	 
	13,605,363

	 
	71,218,263

	Murray etal

	 
	7,000,000

	 
	16,333,333,

	 
	23,333,333

	Employee Option pool

	 
	—

	 
	1,600,000

	 
	1,600,000

	Bridge Investors

	 
	—

	 
	36,150,023

	 
	36,150,023

	Total Shares Outstanding

	 
	125,473,992

	 
	101,941,773

	 
	227,415,765

Schedule A - 1

SCHEDULE B

INDEBTEDNESS

													
	Voyant International Corporation

	Schedule of Debts as of June 6, 2008 (Unaudited)

	 

	Name

	 
	Date Made

	 
	Outstanding

	 
	Interest

	 
	Form

	 
	Date Due

	Jack Levitt

	     

	10-Sep-07

	     

	$

	25,000

	     

	12

	%

	     

	Convertible note

	     

	9-Sep-08

	Donald Sandler

	 
	10-Sep-07

	 
	$

	25,723

	 
	12

	%

	 
	Convertible note

	 
	9-Sep-08

	Harold Seidel

	 
	10-Oct-07

	 
	$

	51,447

	 
	12

	%

	 
	Convertible note

	 
	9-Oct-08

	Buckeye Management

	 
	13-Dec-07

	 
	$

	102,411

	 
	12

	%

	 
	Convertible note

	 
	12-Dec-08

	John Shaw

	 
	09-Jan-08

	 
	$

	133,551

	 
	12

	%

	 
	Convertible note

	 
	8-Jan-09

	Leslie Rich

	 
	01-Feb-08

	 
	$

	49,409

	 
	12

	%

	 
	Convertible note

	 
	31-Jan-09

	Donna Tepper

	 
	07-Mar-08

	 
	$

	22,724

	 
	12

	%

	 
	Convertible note

	 
	7-Mar-09

	Robert Holtz

	 
	12-Dec-05

	 
	$

	300,000

	 
	None

	 
	 
	Demand note

	 
	None

	WAA, LLC

	 
	11-Sept-06

	 
	$

	300,000

	 
	8

	%

	 
	Term note

	 
	11-Aug-09

	Shai Stern

	 
	05-Jul-07

	 
	$

	61,574

	 
	12

	%

	 
	Term note

	 
	None

	Maple Ridge Insurance Service

	 
	29-Feb-08

	 
	$

	2,016,849

	 
	15

	%

	 
	Term note

	 
	25-Oct-08

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

	Notes:

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

	- Does not include payables and accruals from normal operations

	- Interim period numbers are not audited or reviewed

Schedule B - 1

SCHEDULE C

SUBSIDIARIES

	
	Voyant International Corporation 

	RocketStream Holding Corporation

	Zeroes & Ones Technologies, Inc.

	RocketStream, Inc.

Schedule C - 1

SCHEDULE D

LITIGATION; TAXES

On February 20, 2008 the Company was served with a complaint from Joseph Montesi related to an alleged loan transaction with Zeros & Ones, Inc. dating back to 2001. The original loan is alleged to have been $100,000. Plaintiff alleges damages for non-payment and the Company's failure to issue a warrant for 250,000 shares of the Company's common stock.  The Company believes the complaint is without merit and intends to vigorously defend against this action.

Schedule D - 1

EXHIBIT A

PROMISSORY NOTE

See attached.

Exh A - 1

EXHIBIT B

SECURITY AGREEMENT

See attached.

Exh B - 1

EXHIBIT C

COMMON STOCK PURCHASE WARRANT

See attached.

EXHIBIT D

INTERCREDITOR AGREEMENT

See attached.United States Securities and Exchange Commission EDGAR Filing

EXHIBIT 10.1

PHARMANET DEVELOPMENT GROUP, INC.

2004 EMPLOYEE STOCK PURCHASE PLAN

(As Amended and Restated March 5, 2008)

The following constitute the provisions of the 2004 Employee Stock Purchase Plan (herein called the “Plan”) of PharmaNet Development Group, Inc. (the “Company”).

1.

Purpose.  The purpose of the Plan is to provide employees of the Company and its subsidiaries with an opportunity to purchase Common Stock of the Company through payroll deductions.  It is the intention of the Company to have the Plan qualify as an “Employee Stock Purchase Plan” under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”).  The provisions of the Plan shall, accordingly, be constructed so as to extend and limit participation in a manner consistent with the requirements of that section of the Code.

2.

Definitions.

(a)

“Board” shall mean the Board of Directors of the Company.

(b)

“Code” shall mean the Internal Revenue Code of 1986, as amended.

(c)

“Common Stock” shall mean the Common Stock, $.001 par value, of the Company.

(d)

“Company” shall mean PharmaNet Development Group, Inc., a Delaware corporation.

(e)

“Compensation” shall mean base salary.

(f)

 “Compensation Committee” shall mean the compensation committee of the Company’s Board.

(g)

 “Corporate Transaction” shall mean the occurrence, in a single transaction or in a series of related transactions, of any one or more of the events:

(i)

a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company; 

(ii)

a sale or other disposition of at least 50% of the outstanding securities of the Company; or

(iii)

a merger, consolidation or similar transaction unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction.

(h)

 “Designated Subsidiaries” shall mean the Subsidiaries which have been designated by the Board from time to time, in its sole discretion, as eligible to participate in the Plan.

(i)

“Employee” shall mean any person who is customarily employed for at least 20 hours per week and has been so employed for at least 90 days continuously by the Company or one of its Designated Subsidiaries.

(j)

“International Plan” shall mean the Company’s 2008 International Employee Stock Purchase Plan.

(k)

“Plan” shall mean this Employee Stock Purchase Plan.

(l)

“Subsidiary” shall mean any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

3.

Eligibility.

(a)

Any Employee as defined in Section 2 shall be eligible to participate in the Plan, subject to limitations imposed by Section 423(b) of the Code.

(b)

Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) if, immediately after the grant, such Employee would own shares (including outstanding options to purchase) of stock possessing 5% or more of the total combined voting power or value of all classes of shares of the Company or any Subsidiary of the Company, (ii) if such employee is an executive officer of the Company who is required to file ownership reports under Section 16(a) of the Securities Exchange Act of 1934, or (iii) which permits his rights to purchase shares under the Plan and other stock option plans of the Company to accrue at a rate which exceeds $25,000 of the fair market value of the shares (determined at the time such option is granted) for each calendar year in which such stock option is outstanding at any time.  For purposes of (i) above, the rules of Section 424(d) of the Code shall apply in determining the stock ownership of any Employee and stock which such Employee may purchase under all outstanding options shall be treated as stock owned by such Employee.

4.

Offering Dates.  The Plan shall be implemented by one offering during each six-month period of the Plan.  Offerings will commence on the first business day in January and July each year and end on the last business day in June and December each year respectively.  The Compensation Committee shall have the power to change the duration of offering periods with respect to future offerings without stockholder approval, if such change is announced at least 15 days prior to the scheduled beginning of the first offering period to be affected.

5.

Participation.

(a)

An eligible Employee may become a participant in the Plan by completing a subscription agreement authorizing a payroll deduction on the form provided by the Company, 

2

and filing it with the Company in accordance with the procedures specified by the Company prior to the applicable offering date.

(b)

Payroll deductions for a participant shall commence on the first payday following the offering date and shall end on the payday ending with or immediately prior to the termination date of the offering to which such authorization is applicable, unless sooner terminated by the participant as provided in Section 10.

6.

Payroll deductions.

(a)

At the time a participant files his subscription agreement, he shall elect to have payroll deductions made on each payday during the offering period in any multiple of one percent (1%), up to a maximum of ten percent (10%), of the Compensation which he is to receive on such payday.

(b)

All payroll deductions authorized by a participant shall be credited to his account under the Plan.  A participant may not make any additional payments into such account.

(c)

A participant may discontinue his participation in the Plan as provided in Section 10, or may lower, but not increase, the rate of his payroll deductions during the offering by completing and filing with the Company a new authorization for payroll deduction.  The change in rate shall be effective within 15 days following the Company’s receipt of the new authorization.

7.

Grant of Option.

(a)

At the beginning of each offering period, each eligible Employee participating in the Plan shall be granted an option to purchase up to that number of shares of the Company’s Common Stock determined by dividing the amount accumulated in such employee’s payroll deduction account during such offering period by the per share option price set forth in Section 7(b) up to a maximum of 1,000 shares of the Company’s Common Stock, subject to the limitations set forth in Section 3(b).

(b)

The option price per share of such shares shall be the lesser of: (i) 85% of the fair market value of a share of the Common Stock of the Company at the commencement of the offering period or (ii) 85% of the fair market value of a share of the Common Stock of the Company at the time the option is exercised at the termination of the six-month offering period.

(c)

For purposes of this Section 7, the fair market value of the Company’s Common Stock on a given date shall be the reported closing price for that date or, if there are no sales on such date, on the last trading date on which there were sales of Common Stock, as reported by the principal market for the Common Stock.

8.

Exercise of Option.  Unless a participant withdraws from the Plan as provided in Section 10, his option for the purchase of shares shall be exercised automatically at the end of the offering period, and the maximum number of full shares subject to option shall be purchased for him at the applicable option price with the accumulated payroll deductions in his account.  

3

During his lifetime, a participant’s option to purchase shares hereunder is exercisable only by him.

9.

Excess Payroll Deductions.  Any payroll deductions not applied to the purchase of shares on any purchase date because they are not sufficient to purchase a whole share shall be held for the purchase of shares on the next purchase date.  However, any payroll deductions not applied to the purchase of shares by reason of the limitation on the maximum number of shares purchasable per participant on the purchase date set forth in Section 7(a) shall be promptly refunded.

10.

Delivery.  As promptly as practicable after the termination of each offering, the Company shall arrange the delivery to or for the benefit of each participant, of a certificate representing the shares purchased upon exercise of his option.  

11.

Withdrawal; Termination of Employment.

(a)

A participant may withdraw all but not less than all the payroll deductions credited to his account under the Plan at any time prior to the end of the offering period by giving written notice to the Company.  All of the participant’s payroll deductions credited to his account shall be paid to him promptly after receipt of his notice of withdrawal and his option for the current offering period shall be automatically terminated, and no further payroll deductions for the purchase of shares shall be made for him during the offering period.

(b)

Upon termination of the participant’s employment prior to the end of the offering period for any reason, including retirement or death, the payroll deductions credited to his account shall be returned to him or, in the case of his death, to the person or persons entitled thereto under Section 14, and his option shall be automatically terminated.

(c)

In the event an Employee fails to remain in the continuous employ of the Company or a Designated Subsidiary for at least 20 hours per week during the offering period in which the employee is a participant, he shall be deemed to have elected to withdraw from the Plan and the payroll deductions credited to his account shall be returned to him and his option terminated.

(d)

A participant’s withdrawal from an offering shall not have any effect upon his eligibility to participate in a succeeding offering or in any similar plan which may hereafter be adopted by the Company or a Designated Subsidiary.

12.

Interest.  No interest shall accrue on the payroll deductions of a participant in the Plan. 

13.

Common Stock.

(a)

The maximum number of shares of the Company’s Common Stock which shall be made available for sale in the aggregate under the Plan and the International Plan shall be 700,000 shares, subject to adjustment upon changes in capitalization of the Company as provided in Section 18.  The shares to be sold to participants under the Plan may, at the election of the Company, be in the Company’s sole discretion, either treasury shares, shares authorized 

4

but unissued, or shares purchased on the open market.  If the total number of shares, which would otherwise be subject to options granted pursuant to Section 7(a) hereof and pursuant to the International Plan, at the beginning of an offering period exceeds the number of shares then available under the Plan and the International Plan (after deduction of all shares for which options have been exercised or arc then outstanding), the Company shall allocate options for shares remaining available for option grant pro rata among the participants in accordance with the amounts otherwise determined pursuant to Section 7(a).  The Compensation Committee may make rules regarding the pro rate deduction.  In such event, the Company shall give written notice of such reduction of the number of shares subject to the option to each participant affected thereby and shall similarly reduce the rate of payroll deductions, if necessary.

(b)

A participant shall have no interest or voting right in shares covered by his option until such option has been exercised.

14.

Administration.  The Plan shall be administered by the Compensation Committee which may make rules regarding administration of the Plan.  The administration, interpretation or application of the Plan by the Compensation Committee shall be final, conclusive and binding upon all participants.

15.

Designation of Beneficiary.

(a)

A participant may file a written designation of a beneficiary (or beneficiaries) who is to receive any shares or cash or both to which the participant may be entitled under the Plan at the time of his death.

(b)

Such designation of a beneficiary (or beneficiaries) may be changed by the participant at any time by written notice to the Company.  In the event of the death of a participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall deliver any shares and any cash to which the participant was entitled to the executor or administrator of the estate of the participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver any such shares and any such cash to the spouse or children of the participant, or if no spouse or no child is known to the Company, then to such other person as the Company may designate.

16.

Transferability.  Neither payroll deductions credited to a participant’s account nor any rights with regard to the exercise of any option or rights to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 14 hereof) by the participant.  Any such attempt at assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds in accordance with Section 10.

17.

Use of Funds.  All payroll deductions received or held by the Company or a Designated Subsidiary under the Plan may be used by the Company or a Designated Subsidiary for any corporate purpose, and the Company or a Designated Subsidiary shall not be obligated to segregate such payroll deductions.

5

18.

Reports.  Individual accounts shall be maintained for each participant in the Plan.  Statements of account shall be given to participating Employees semiannually promptly following the stock purchase date, which statements shall set forth the amount of payroll deductions, the per share purchase price, the number of shares purchased and the remaining cash balance, if any.

19.

Adjustments Upon Changes in Capitalization/Corporate Transaction.  Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares, spin-off transaction or other change affecting the outstanding Common Stock as a class without the Company’s receipt of consideration, or should the value of outstanding shares of Common Stock be substantially reduced as a result of a spin-off transaction or an extraordinary dividend or distribution, or should there occur any merger, consolidation or other reorganization, then equitable adjustments shall be made to the number and/or class of securities covered by each option under the Plan which has not yet been exercised and the number and/or class of securities which have been authorized for issuance under the Plan but for which options have not yet been granted, as well as the price per share of Common Stock covered by each option under the Plan which has not yet been exercised, shall be equitably adjusted.  Conversion of any convertible securities of the Company shall be deemed to have been “‘effected” with the receipt of consideration and therefore not require any adjustment.  Such adjustment shall be made by the Compensation Committee, whose determination in that respect shall be final, binding and conclusive.  Except as expressly provided herein, no sale by the Company of shares of capital stock of any class shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an option.

In the event of a Corporate Transaction, then: (i) any surviving or acquiring corporation may continue or assume options outstanding under the Plan or may substitute similar rights (including a right to acquire the same consideration paid to stockholders in the Corporate Transaction) for those outstanding, under the Plan, or (ii) if any surviving or acquiring corporation does not assume such options or does not substitute similar rights for options outstanding under the Plan, then the participants’ accumulated payroll deductions (exclusive of any accumulated interest that cannot be applied toward the purchase of shares of Common Stock under the terms of the offering) shall be used to purchase shares of Common Stock immediately prior to the Corporate Transaction under the ongoing offering, and the participants’ options under the ongoing offering shall terminate immediately after such purchase.

20.

Amendment or Termination.  The Board of Directors of the Company may at any time terminate or amend the Plan.  No termination shall affect options previously granted.  No amendment shall make any change in any option granted under the Plan which adversely affects the right of any participant.  No amendment shall be made without prior approval of the stockholders of the Company if such amendment would:

(a)

increase the number of shares that may be issued under the Plan except as provided in Section 18; 

(b)

alter the purchase price formula so as to reduce the purchase price payable for the shares under the Plan;

6

(c)

modify the eligibility requirements for participation in the Plan; or

(d)

make any change which is not consistent with applicable law including the rules of the Securities and Exchange Commission or the principal trading market for the Common Stock.

21.

Notices.  All notices or other communications by a participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt hereof.

22.

Stockholder Approval.  This Plan shall be subject to approval by the affirmative vote of the holders of a majority of the outstanding shares of Common Stock of the Company present or represented and entitled to vote thereon.

23.

Conditions Upon Issuance of Shares.  Shares shall not be issued with respect to any option unless the exercise of such option and issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any principal trading market upon which the shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance.  As a condition to the exercise of an option, the Company may require the person exercising such option to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned applicable provisions of law.

24.

No Employment Contract.  The Plan and offerings do not constitute an employment contract.  Nothing in the Plan or in the offerings shall in any way alter the at will nature of a participant’s employment or be deemed to create in any way whatsoever any obligation on the part of any participant to continue in the employ of the Company or a Subsidiary, or on the part of the Company or a Subsidiary to continue the employment of a participant.

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]